Quoin Pharmaceuticals stock has surged after successfully achieving target rapamycin loadings. The company’s breakthrough in drug development has captured investor interest, leading to a significant increase in stock value. This achievement marks a milestone in the pharmaceutical industry, with potential for future growth and success. Investors are optimistic about the company’s prospects moving forward.

Read more at Investing.com: Quoin Pharmaceuticals stock soars after achieving target rapamycin loadings